Neurochemistry of Alzheimer's disease

Psychiatry

Volumn 4, Issue 1, 2005, Pages 40-42

  Keverne, Jessica ^a   Ray, Melissa ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; choline acetyltransferase; cholinergic system; cholinesterase inhibitors; glutamate; monoamines; old age psychiatry

Indexed keywords

EID: 77950282479     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1383/psyt.4.1.40.58307     Document Type: Article

References (13)

1. Francis P.T. Glutamatergic systems in Alzheimer's disease. Int J Geriatr Psychiatry 18 Suppl 1 (2003) S15-S21
2. Francis P.T., Palmer A.M., Sims N.R., et al. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N Engl J Med 313 (1985) 7-11
3. Nordberg A., Hartvig P., Lilja A., et al. Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography. J Neural Transm Park Dis Dement Sect 2 (1990) 215-224
4. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., and Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 2 6150 (1978) 1457-1459
5. Perry E., Walker M., Grace J., and Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness. Trends Neurosci 22 (1999) 273-280
6. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., and DeLong M.R. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10 (1981) 122-126
7. Bartus B.T. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163 (2000) 495-529
8. Court J., Martin-Ruiz C., Piggott M., Spurden D., Griffiths M., and Perry E. Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry 49 (2001) 175-184
9. Dringenberg C. Alzheimer's disease: more than a 'cholinergic disorder' - evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia. Behav Brain Res 115 (2000) 235-249
10. Francis P.T., Palmer A.M., Snape M., and Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 66 (1999) 137-147
11. Grossberg G.T. The ABC of Alzheimer's disease: behavioral symptoms and their treatment. Int Psychogeriatr 1 (2002) 27-49
12. Hellstrom-Lindahl E., Court J., Keverne J., et al. Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice. Eur J Neurosci 19 (2004) 2703-2710
13. Mufson E.J., Ginsberg S.D., Ikonomovic M.D., and DeKosky S.T. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat 26 (2003) 233-242